Logo do repositório
 
Publicação

Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria

2024-02Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorGonçalves, Tiago
dc.contributor.authorMarques, Andreia T.
dc.contributor.authorManageiro, Vera
dc.contributor.authorTanoeiro, Luis
dc.contributor.authorVital, Joana S.
dc.contributor.authorDuarte, Aida
dc.contributor.authorVítor, Jorge M. B.
dc.contributor.authorCaniça, Manuela
dc.contributor.authorGaspar, Maria Manuela
dc.contributor.authorVale, Filipa F.
dc.date.accessioned2025-08-14T19:26:40Z
dc.date.available2025-08-14T19:26:40Z
dc.date.issued2024-02
dc.date.updated2024-01-25T16:33:38Z
dc.description© 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.pt_PT
dc.description.abstractEnterobacteriaceae species are part of the 2017 World Health Organization antibiotic-resistant priority pathogens list for development of novel medicines. Multidrug-resistant Klebsiella pneumoniae is an increasing threat to public health and has become a relevant human pathogen involved in life-threatening infections. Phage therapy involves the use of phages or their lytic endolysins as bioagents for the treatment of bacterial infectious diseases. Gram-negative bacteria have an outer membrane, making difficult the access of endolysins to the peptidoglycan. Here, three endolysins from prophages infecting three distinct Enterobacterales species, Kp2948-Lys from K. pneumoniae, Ps3418-Lys from Providencia stuartii, and Kaer26608-Lys from Klebsiella aerogenes, were purified and exhibited antibacterial activity against their specific bacterium species verified by zymogram assays. These three endolysins were successfully associated to liposomes composed of dimyristoyl phosphatidyl choline (DMPC), dioleoyl phosphatidyl ethanolamine (DOPE) and cholesteryl hemisuccinate (CHEMS) at a molar ratio (4:4:2), with an encapsulation efficiency ranging from 24 to 27%. Endolysins encapsulated in liposomes resulted in higher antibacterial activity compared to the respective endolysin in the free form, suggesting that the liposome-mediated delivery system enhances fusion with outer membrane and delivery of endolysins to the target peptidoglycan. Obtained results suggest that Kp2948-Lys appears to be specific for K. pneumoniae, while Ps3418-Lys and Kaer26608-Lys appear to have a broader antibacterial spectrum. Endolysins incorporated in liposomes constitute a promising weapon, applicable in the several dimensions (human, animals and environment) of the One Health approach, against multidrug-resistant Enterobacteriaceae.pt_PT
dc.description.sponsorshipF.F.V. was funded by Fundação para a Ciência e a Tecnologia (FCT) through a project grant (PTDC/BTM-SAL/28978/2017) that supported this work. The work is partially supported by National funds from FCT, projects UIDB/04138/2020, UIDP/04138/2020, UIDB/00211/2020 and UIDB/04046/2020 (DOI https://doi.org/10.54499/UIDB/04046/2020)pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationGonçalves T, Marques AT, Manageiro V, Tanoeiro L, Vital JS, Duarte A, et al. Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria. International Journal of Pharmaceutics 2024;651:123758. https://doi.org/10.1016/j.ijpharm.2023.123758pt_PT
dc.identifier.doi10.1016/j.ijpharm.2023.123758pt_PT
dc.identifier.slugcv-prod-3578660
dc.identifier.urihttp://hdl.handle.net/10400.5/102921
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.relationPhage-Enzybiotic: dealing with critical pathogenic antibiotic-resistant bacteria
dc.relationResearch Institute for Medicines
dc.relationResearch Institute for Medicines
dc.relationCenter for the Study of Animal Science
dc.relationBiosystems and Integrative Sciences Institute
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0378517323011808pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectKlebsiella pneumoniaept_PT
dc.subjectEnterobacteriaceaept_PT
dc.subjectPhage therapypt_PT
dc.subjectEndolysinpt_PT
dc.subjectAntibiotic resistancept_PT
dc.subjectLiposomept_PT
dc.titleAntimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteriapt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardNumberPTDC/BTM-SAL/28978/2017
oaire.awardNumberUIDB/04138/2020
oaire.awardNumberUIDP/04138/2020
oaire.awardNumberUIDB/00211/2020
oaire.awardNumberUIDB/04046/2020
oaire.awardTitlePhage-Enzybiotic: dealing with critical pathogenic antibiotic-resistant bacteria
oaire.awardTitleResearch Institute for Medicines
oaire.awardTitleResearch Institute for Medicines
oaire.awardTitleCenter for the Study of Animal Science
oaire.awardTitleBiosystems and Integrative Sciences Institute
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBTM-SAL%2F28978%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04138%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04138%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00211%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04046%2F2020/PT
oaire.citation.startPage123758pt_PT
oaire.citation.titleInternational Journal of Pharmaceuticspt_PT
oaire.citation.volume651pt_PT
oaire.fundingStream3599-PPCDT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
person.familyNameDuarte
person.familyNameVítor
person.familyNamede Jesus Guilherme Gaspar
person.familyNameVale
person.givenNameAida
person.givenNameJorge
person.givenNameMaria Manuela
person.givenNameFilipa
person.identifier2524696
person.identifierC-2024-2014
person.identifier.ciencia-idD517-F4DB-17C1
person.identifier.ciencia-idFF19-99F4-3964
person.identifier.ciencia-id3A10-0732-13F5
person.identifier.ciencia-id4718-00EF-4BF0
person.identifier.orcid0000-0002-0616-4650
person.identifier.orcid0000-0001-6486-3444
person.identifier.orcid0000-0001-6814-7226
person.identifier.orcid0000-0003-4635-0105
person.identifier.ridM-5272-2013
person.identifier.ridM-3279-2013
person.identifier.ridC-3570-2013
person.identifier.scopus-author-id35495748300
person.identifier.scopus-author-id7801493621
person.identifier.scopus-author-id15834627800
person.identifier.scopus-author-id17136133700
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.cv.cienciaid4718-00EF-4BF0 | Ana Filipa Ferreira do Vale
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationf7620f51-a5ef-4e71-9cf5-3f34eb294a9d
relation.isAuthorOfPublicationbe15e90f-9cc9-4ad0-b9fd-465236b72e9a
relation.isAuthorOfPublication9e3a2d04-322f-4f0f-877c-45481624aa05
relation.isAuthorOfPublicationb2d398b3-1980-4cc0-9905-9e478bdb85a9
relation.isAuthorOfPublication.latestForDiscoveryb2d398b3-1980-4cc0-9905-9e478bdb85a9
relation.isProjectOfPublication9fce9093-4b23-49da-a836-6174c07bb753
relation.isProjectOfPublicationbb00962c-ed82-4d7a-bc37-61df49767d93
relation.isProjectOfPublicationa21e6964-b01b-421e-9356-1ff6579cdd5c
relation.isProjectOfPublication2140bd43-b8e0-4ee3-b374-ec1b13ca82e4
relation.isProjectOfPublicationcd397b4c-17e6-40cc-8cdd-1dd1c0da5113
relation.isProjectOfPublication.latestForDiscovery2140bd43-b8e0-4ee3-b374-ec1b13ca82e4

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
1-s2.0-S0378517323011808-main.pdf
Tamanho:
3.57 MB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

FF - CiênciaVitae - Faculdade de Farmácia